← Back to Search

Behavioural Intervention

Reading Program for Language Developmental Disorders

N/A
Recruiting
Led By Laura M Justice, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primarily communicates in English
Primary complaint of impaired language skills
Must not have
No known additional diagnoses causal of developmental language disorder including hearing loss
No known additional diagnoses causal of developmental language disorder including severe intellectual disability
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month follow-up, 12 month follow-up, 18 month follow-up, 24 month follow up.
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study the effects of a caregiver-led reading program called Sit Together and Read (STAR) on children aged 4 to 5 with developmental language disorder. The study will assess how STAR

Who is the study for?
This trial is for caregivers of children ages 4 to 5 who are receiving or waiting for speech services due to language disorders. The child should primarily communicate in English and not have other conditions like hearing loss, severe intellectual disability, or autism that could cause language issues.
What is being tested?
The study tests the effectiveness of a reading program called STAR on improving literacy skills in young children with developmental language disorder. It will also assess if monetary rewards or text encouragement help caregivers conduct more reading sessions.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there are no direct physical side effects. However, it's important to consider the time commitment and potential stress related to consistent participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I primarily communicate in English.
Select...
I am having trouble with speaking or understanding language.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have any conditions like hearing loss that could explain my language disorder.
Select...
I do not have any conditions known to cause language disorders besides intellectual disability.
Select...
I do not have any conditions like autism that could explain my language disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month follow-up, 12 month follow-up, 18 month follow-up, 24 month follow up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month follow-up, 12 month follow-up, 18 month follow-up, 24 month follow up. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Phonological Awareness Literacy Screening (PALS): Alphabet Knowledge and Name Writing
Preschool Word and Print Awareness (PWPA)
The Reading House (THR)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: STAR OnlyExperimental Treatment1 Intervention
Typical implementation of Sit Together and Read (STAR)
Group II: STAR + text encouragementExperimental Treatment2 Interventions
Typical implementation of Sit Together and Read (STAR) plus caregivers receive encouraging text messages
Group III: STAR + RewardExperimental Treatment2 Interventions
Typical implementation of Sit Together and Read (STAR) plus additional small monetary incentives for caregivers
Group IV: Untreated ControlActive Control1 Intervention
Caregivers read to child as usual over 15 week period.

Find a Location

Who is running the clinical trial?

Nationwide Children's HospitalOTHER
348 Previous Clinical Trials
5,227,490 Total Patients Enrolled
Ohio State UniversityLead Sponsor
871 Previous Clinical Trials
655,652 Total Patients Enrolled
Laura M Justice, PhDPrincipal InvestigatorOhio State University
~213 spots leftby Jul 2028